mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability
Top Cited Papers
Open Access
- 1 May 2021
- journal article
- review article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 601, 120586
Abstract
No abstract availableKeywords
Funding Information
- Universiteit Leiden
This publication has 74 references indexed in Scilit:
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Degradation of mRNAs that lack a stop codon: a decade of nonstop progressWIREs RNA, 2012
- Quantification of RNA integrity and its use for measurement of transcript numberNucleic Acids Research, 2012
- GC content around splice sites affects splicing through pre-mRNA secondary structuresBMC Genomics, 2011
- Impact of freezing on pH of buffered solutions and consequences for monoclonal antibody aggregationBiotechnology Progress, 2009
- Immunize and disappear—Safety-optimized mRNA vaccination with a panel of 29 allergensJournal of Allergy and Clinical Immunology, 2009
- The Many Pathways of RNA DegradationCell, 2009
- Freeze-drying of nanoparticles: Formulation, process and storage considerations☆Advanced Drug Delivery Reviews, 2006
- Rapid purification of RNAs using fast performance liquid chromatography (FPLC)RNA, 2006
- Peroxide accumulation in detergentsJournal of Biochemical and Biophysical Methods, 1994